Concepedia

I. Toledano

IT

Statistics

Publications

3

Citations

328

H-Index

3

Active since

2012

Affiliations

Institut Curie(Current)

I. Toledano is an author at Institut Curie specializing in oncology, medicine, and radiation treatment planning.

Publications per year

2012–2023

3

Publications

3

Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer

Hope S. Rugo, Fabrice André, Toshinari Yamashita et al. · Annals of Oncology · 2020 · 187 citations · Full text

Medicine, Oncology, Pharmacology +15

Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004–03

I. Toledano, P. Gräff, Antoine Serre et al. · Radiotherapy and Oncology · 2012 · 131 citations

Medicine, Oncology, Radiation Oncology +11

LBA62 Durvalumab after radiotherapy (RT) in patients with unresectable stage III NSCLC ineligible for chemotherapy (CT): Primary results from the DUART study

A.R.R. Filippi, M.R. García-Campelo, J Paoli et al. · Annals of Oncology · 2023 · 10 citations · Full text

Medicine, Oncology, Radiation Oncology +10

1–3 of 3